Screening: studies
comparing microbatch with vapor diffusion
The table below summarizes the results of several studies where microbatch
was compared to vapor diffusion in screening experiments (i.e. searching for
initial crystallization conditions). All the studies that we know of have
been included.
|
|
|
Proteins
|
Conditions
|
MB
|
VD
|
Extra hits for MB %
|
Unique to MB
|
Unique to VD
|
1996
|
Baldock
et al.
|
Douglas Ins.
|
6
|
48
|
43
|
41
|
5%
|
17
|
15
|
2000
|
D’Arcy
et al.
|
Hoffmann
– La
Roche
|
10
|
48
|
104
|
62
|
68%
|
|
|
2001
|
Noordeen
et al.
|
Novartis Pharma
|
8
|
48 - 576
|
145
|
153
|
-5%
|
95
|
103
|
|
M. Sugahara
|
SPring8
|
6
|
288
|
100
|
84
|
19%
|
|
|
|
TOTAL
|
|
30
|
|
392
|
340
|
15%
|
|
|
All of these studies except the first used only a "Modified
Microbatch" method. This refers to microbatch modified by using a 50:50 mixture of
silicone oil and paraffin oil to cover the drops ("Al's Oil").
The silicone is slightly permeable to water, and allows slow evaporation.
This gives a scanning effect (similar to vapor diffusion with salt, but not PEG) where gradually
increasing concentrations of protein and precipitants are sampled. This
method has been shown to find more hits than using pure paraffin and is now
generally used for regular microbatch screening experiments.
More recently, D'Arcy and colleagues (2003) have shown that
more hits can be found by using pure silicone oil to cover the drops in place of
the silicone / paraffin mixture. The hits also appear much more rapidly -
taking about 9 days instead of up to 70 using the mixture. The disadvantage
of using pure silicone is that crystals do not last for long, so this method is
particularly suitable for use with automatic imaging systems.
References:
P.F.M. Baldock, V. Mills, P.D. Shaw Stewart. A comparison of microbatch
and vapour diffusion for initial screening of crystallization conditions.
Journal of
Crystal
Growth.
168 (1996), pp 170-174 or: http://www.douglas.co.uk/rep2.htm
A. D’Arcy, G.E. Dale, M. Stihle, B. D’Arcy.
Results reported at the 8th International Conference on the
Crystallization of Biological Macromolecules,
May 18, 2000
.
N. Noordeen and S.
Cowan-Jacob. Novartis Pharma AG. https://www.hamptonresearch.com/documents/ramc/P6.ppt
Misuaki Sugahara, Riken
Harima Institute, SPring8. Personal
communication.
A. D'Arcy, A. Mac Sweeney, M. Stihle, A. Haber. The advantages of using a
modified microbatch method for rapid screening of protein crystallization
conditions. Acta Crystallographica Section D 59 (2003), pp 396-399.
|